HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of Dexon and Mersilene sutures in the closure of primary laparotomy incisions.

Abstract
The study is a comparison of Dexon (polyglycolic acid) and Mersilene (polyester) sutures when employed for the primary closure of the peritoneum and aponeurotic layer in primary laparotomy incisions. The material comprises 308 closures of abdominal wounds with interrupted 2-0 sutures (United States Pharmacopeia) in the aponeurosis and continuous 2-0 suture of the peritoneum. One half of the wound was closed with Dexon and the other half with Mersilene, so that the patient acted as his own control. No significant difference was found between the two materials as evaluated from the occurrence of wound rupture within 10 days and incisional hernia within 90 days of the operation. Suture granulomas occurred in 9% of the half wounds sutured with Mersilene. The present clinical investigation demonstrates that Dexon sutures are as reliable as unabsorbable material. Dexon is superior to unabsorbable material as suture granulomas were not seen when Dexon was employed.
AuthorsJ Kjaergaard, N P Laursen, C M Madsen, A Tilma, C Zimmermann-Nielsen
JournalActa chirurgica Scandinavica (Acta Chir Scand) Vol. 142 Issue 4 Pg. 315-8 ( 1976) ISSN: 0001-5482 [Print] Sweden
PMID785915 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Polymers
  • Polyglycolic Acid
Topics
  • Adolescent
  • Adult
  • Aged
  • Bile Ducts (surgery)
  • Clinical Trials as Topic
  • Colon (surgery)
  • Female
  • Gallbladder (surgery)
  • Granuloma (etiology)
  • Hernia (etiology)
  • Humans
  • Laparotomy
  • Male
  • Middle Aged
  • Polyglycolic Acid
  • Polymers
  • Postoperative Complications
  • Rupture (etiology)
  • Stomach (surgery)
  • Sutures (standards)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: